LAUSR

Acute pulmonary oedema (APE) is one of the most common causes of unscheduled hospital admissions among patients 65 years old or older [1, 2], with up to half being critically ill [2]. APE is associated with a high mortality and rate of re-hospitalisation. Whilst in-hospital mortality ranges from 4 to 10%, the readmission rate for APE increases with time after discharge, ranging from 15% at 1 month to 45–50% at 6 months. One in three APE patients dies within 1 year [1, 2]. In this document we outline 10 key questions ICU specialists should address when managing APE.